CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570)
Sequoia Pharmaceuticals, Inc. is engaged in the discovery and development of antiviral therapeutics, with a focus on developing new treatments for drug-resistant infectious diseases such as HIV/AIDS and HCV-induced hepatitis. Sequoia Pharmaceuticals ...Show all
Company (Alive / Active)
Phone: 240-632-0094
401 Professional Drive
Suite 200
Gaithersburg, 20879
Maryland, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Sequoia Pharmaceuticals | $57M | Jan 18, 2007 |
| BlueWillow Biologics | $90.6M | Apr 8, 2020 |
| Avidimer Therpeutics | $0M | Dec 1, 2020 |
| See all 16 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Compositions and methods for inhibiting cytochrome p450 | Jan 11, 2016 | Dec 26, 2017 | Patent |
| Compositions and methods for inhibiting cytochrome p450 2d6 | Jul 29, 2014 | Mar 28, 2017 | Patent |
| Diamide inhibitors of cytochrome p450 | Dec 09, 2014 | Jan 10, 2017 | Patent |
| Compositions and methods for inhibiting cytochrome p450 | Jul 09, 2013 | Jan 12, 2016 | Patent |
| Methods for inhibiting drug degradation | Feb 23, 2009 | Feb 10, 2015 | Patent |
